Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

Insiders Buy More Than $41M Of 2 Penny Stocks

Published 02/06/2022, 13:19
Updated 02/06/2022, 14:12
© Reuters.  Insiders Buy More Than $41M Of 2 Penny Stocks
SCOR
-
EVLO
-

US crude oil futures traded lower this morning on Thursday. Investors, meanwhile, focused on some notable insider trades.

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.3

Evelo Biosciences

  • The Trade: Evelo Biosciences, Inc. (NASDAQ: EVLO) 10% owner Noubar Afeyan acquired a total of 27,397,259 shares at an average price of $1.46. To acquire these shares, it cost $40 million.
  • What’s Happening: Evelo Biosciences recently said Luca Scavo Delivered his resignation as the Chief Financial Officer.
  • What Evelo Biosciences Does: Evelo Biosciences Inc is a United States-based biotechnology company. It is engaged in discovering and developing a new class of orally delivered investigational medicines that are intended to act on cells in the small intestine to produce therapeutic effects throughout the body.
comScore
  • The Trade: comScore, Inc. (NASDAQ: SCOR) Director Paul William Livek acquired a total of 600,000 shares at an average price of $1.92. The insider spent around $1.15 million to buy those shares.
  • What’s Happening: comScore, last month, posted a Q1 loss of $0.14 per share.
  • What comScore Does: comScore Inc is a United States-based company that provides digital media analytics services to customers in the media, advertising, and marketing industries.
Also check this: Under Armour And 2 Other Stocks Insiders Are Buying

Don’t forget to check out our premarket coverage here .

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read at Benzinga

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.